Effect of Trimethoprim-Sulfamethoxazole Prophylaxis on Antimicrobial Resistance of Fecal Escherichia coli in HIV-Infected Patients in Tanzania

BACKGROUND: Trimethoprim-sulfamethoxazole (SXT) reduces morbidity and mortality among HIV-infected persons in Africa, but its impact on antimicrobial resistance is of concern. METHODS: HIV-uninfected (group A), HIV-infected but not requiring SXT (group B), and HIV-infected and eligible for SXT (grou...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Morpeth, Susan C., Thielman, Nathan M., Ramadhani, Habib O., Hamilton, John D., Ostermann, Jan, Kisenge, Peter R., Shao, Humphrey J., Reller, L. Barth, Itemba, Dafrosa K., Sam, Noel E., Bartlett, John A., Shao, John F., Crump, John A.
Format: Artigo
Langue:Inglês
Publié: 2008
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2586846/
https://ncbi.nlm.nih.gov/pubmed/18285712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e31816856db
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires